Beclometasonum [Inn-Latin] en es it fr

Beclometasonum [Inn-Latin] Brand names, Beclometasonum [Inn-Latin] Analogs

Beclometasonum [Inn-Latin] Brand Names Mixture

  • none

Beclometasonum [Inn-Latin] Chemical_Formula


Beclometasonum [Inn-Latin] RX_link

Beclometasonum [Inn-Latin] fda sheet

Beclometasonum_[Inn-Latin] FDA

Beclometasonum [Inn-Latin] msds (material safety sheet)

Beclometasonum [Inn-Latin] Synthesis Reference

U.S. Pat. 3,312,590 (1967)

Beclometasonum [Inn-Latin] Molecular Weight

521.042 g/mol

Beclometasonum [Inn-Latin] Melting Point


Beclometasonum [Inn-Latin] H2O Solubility

49.39 mg/L

Beclometasonum [Inn-Latin] State


Beclometasonum [Inn-Latin] LogP


Beclometasonum [Inn-Latin] Dosage Forms

Oral inhalation; Nasal inhalation; Nasal spray

Beclometasonum [Inn-Latin] Indication

For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older

Beclometasonum [Inn-Latin] Pharmacology

Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps.

Beclometasonum [Inn-Latin] Absorption

Mean peak plasma concentration was 88pg/ml at 0.5 hour

Beclometasonum [Inn-Latin] side effects and Toxicity

The acute toxicity of beclomethasone dipropionate is low. The only harmful effect that follows inhalation of large amounts of the drug over a short period of time is suppression of hypothalamic-pituitary-adrenal (HPA) function. Chronic: The excessive use of beclomethasone dipropionate over a long period could lead to adrenal suppression.

Beclometasonum [Inn-Latin] Patient Information

Beclometasonum [Inn-Latin] Organisms Affected

Humans and other mammals